ACET

Adicet Bio Inc

• TipRanks·2d ago

  JonesTrading Keeps Their Buy Rating on Adicet Bio (ACET)

• NASDAQ·03/24 16:00

  Adicet Bio (ACET) Upgraded to Buy: Here's Why

• Dow Jones·03/23 11:33

  Adicet Bio Price Target Cut to $27.00/Share From $50.00 by HC Wainwright & Co.

• Dow Jones·03/23 11:33

  Adicet Bio Is Maintained at Buy by HC Wainwright & Co.

• Benzinga·03/23 11:23

  HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

• TipRanks·03/23 10:16

  Adicet Bio: Cash Runway to 2027 and Differentiated Allogeneic Prula‑cel Pipeline Support Buy Rating and $27 Target

• TipRanks·03/23 10:10

  Adicet Bio price target lowered to $27 from $50 at H.C. Wainwright

• Reuters·03/23 10:09

  ADICET BIO, INC. <ACET.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $27 FROM $50

• Reuters·03/23 07:35

  U.S. RESEARCH ROUNDUP- ArriVent Biopharma, Aveanna Healthcare Holdings, EQT

• TipRanks·03/16 12:30

  Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Teleflex (TFX) and Medacta Group SA (OtherMEDGF)

• TipRanks·03/16 12:00

  Analysts Are Bullish on Top Healthcare Stocks: Protagonist Therapeutics (PTGX), CG Oncology, Inc. (CGON)

• TipRanks·03/16 11:01

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• TipRanks·03/14 16:25

  Guggenheim Keeps Their Buy Rating on Adicet Bio (ACET)

• TipRanks·03/14 06:00

  Clinical Trial Uncertainty Puts Adicet Bio’s Prula-cel Program and Financial Outlook at Risk

• Dow Jones·03/13 13:02

  Adicet Bio Price Target Cut to $100.00/Share From $128.00 by Guggenheim